Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 12 January 2007. doi:10.1136/jcp.2006.042671
Journal of Clinical Pathology 2007;60:717-720
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

CASE REPORT

Pure red cell aplasia associated with type I autoimmune polyglandular syndrome—successful response to treatment with mycophenolate mofetil: case report and review of literature

Milena Bakrac1, Vladimir Jurisic2, Tanja Kostic3, Vera Popovic4, Sandra Pekic4, Nada Kraguljac5, Milica Colovic5

1 Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
2 Institute for Pathophysiology, School of Medicine, University of Kragujevac, Kragujevac, Serbia
3 Institute for Molecular Genetics and Genetic Engineering, Belgrade, Serbia
4 Institute of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
5 Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia

Correspondence to:
Professor V Jurisic
University of Kragujevac, School of Medicine, PO Box 124, 34 000 Kragujevac, Serbia

Accepted 17 November 2006

The first 150 words of the full text of this article appear below.

Pure red cell aplasia (PRCA) is a rare haematological syndrome characterised by anaemia, reticulocytopenia and severe erythroid hypoplasia without alteration in megakaryocytic and myeloid maturation. Immune system irregularity can be mediated by the presence of autoantibodies against erythroid cells or against erythropoietin (Epo), or by hyperactivity of large granular lymphocytes with enhanced T cell or natural killer cell cytotoxicity.1–3 The association between PRCA and other autoimmune diseases such as autoimmune polyglandular syndrome (APS) I is rare.4

The second autoimmune disease, named APS I or autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare hereditary autosomal recessive disorder. It is characterised by the presence of chronic mucocutaneous candidiasis, multiple endocrinopathies (hypoparathyroidism, adrenocortical failure, hypergonadotropic hypogonadism, type I diabetes mellitus and pan-hypopituitarism), and various ectodermal manifestations (enamel dysplasia, nail dystrophy, alopecia, vitiligo and keratopathy).5,6 Clinically, APECED can be confirmed by appearances of at least two of the three features: candidiasis, hypoparathyroidism and adrenocortical failure.5–7 . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs